In a Drosophila model of Huntington's disease, co-expression of wild-type ataxin-3 and polyQ-expanded htt resulted in complete restoration of the neurodegeneration that is typically observed with expression of pathogenic htt alone [162]. This evidence concerns the gene ATXN3 and Huntington disease.